I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 516 ILS 0.76% Market Closed
Market Cap: 248.1m ILS

Net Margin
InterCure Ltd

-17.4%
Current
1%
Average
5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-17.4%
=
Net Income
-62m
/
Revenue
355.6m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
IL
InterCure Ltd
TASE:INCR
248.1m ILS
-17%
US
Eli Lilly and Co
NYSE:LLY
735.9B USD
23%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
404B USD
25%
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK
35%
CH
Roche Holding AG
SIX:ROG
202.1B CHF
14%
CH
Novartis AG
SIX:NOVN
178.4B CHF
25%
UK
AstraZeneca PLC
LSE:AZN
160.5B GBP
14%
US
Merck & Co Inc
NYSE:MRK
205.3B USD
27%
IE
Endo International PLC
LSE:0Y5F
183.8B USD
-126%
US
Pfizer Inc
NYSE:PFE
142.9B USD
13%

InterCure Ltd
Glance View

Market Cap
248.1m ILS
Industry
Pharmaceuticals

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

INCR Intrinsic Value
1 498.88 ILS
Undervaluation 66%
Intrinsic Value
Price
I
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-17.4%
=
Net Income
-62m
/
Revenue
355.6m
What is the Net Margin of InterCure Ltd?

Based on InterCure Ltd's most recent financial statements, the company has Net Margin of -17.4%.

Back to Top